Medtec China 2018 was successfully held in Shanghai
Nov 08, 2018

SHANGHAI, Nov. 7, 2018 /PRNewswire/ -- Medtec China 2018 was successfully held at the Shanghai World Expo Exhibition & Convention Center September 26-28th, 2018. The three-day event succeeded in bringing together 354 exhibitors from 23 countries and regions of the world, serving as a premium quality forum for medical device R&D, production technology, materials, components, manufacturing devices, testing equipment, and regulation service and support for multinational medical device manufacturers to set up production and R&D bases in China.

Numbers of visitors and exhibitors reaches a new high

As a medical device design and manufacturing industry annual grand gathering, Medtec China 2018 received 21,583 visits from 4,643 companies, representing a 17.5% increase compared with 2017. Click here to check the "Post Show Report 2018".

354 exhibitors were represented and the exhibition scale increased by 17%. Exhibitors were mostly satisfied with their exhibiting experience -- more than 85% of exhibitors rebooked booths for the 2019 show. So far, almost 90% of the booth area has already been booked. To secure a booth at Medtec China 2019, please click here.

Assembling the best brands of MedTech in China

As the world-leading exhibition dedicated to the Medical Device Design and Manufacturing Industry in China, Medtec China gathers together both international and domestic brands at the show to meet all kinds of needs from visitors.

Medtec China boasts strong resources in Medical Automation, for example, through the presence of Mickron, Kahle Automation, TP Concept, Leedon, Maider, Shenzhen City North Credibility, and Chongzhan Intelligent.

Medical Materials and Components are also some of Medtec China's strong fields. 3M, Eastman, DSM, and Covestro, as leading companies in the medical materials field, have been attending Medtec China for many years. Furthermore, Furukawa Techno, Suzhou Bank Valley, Teknor Apex, and Wynca have also joined Medtec China over the years as the new generation of exhibitors. With regards to precision components, home suppliers such as Starpoint, Rapid Manufacturing, Shenzhen Sinowares, Changzhou Aron, and Ningbo OULAIKE have also provided various choices to visitors.

The newly-launched REGULATORY STREET appealed to visitors. REGULATORY STREET provides comprehensive regulatory consultant services. Exhibitors knoell Germany GmbH, WuXi AppTec, and NAMSA were present in this zone at Medtec China 2018. The "Regulation Lecture" also took place in this zone.

Germany and Singapore Pavilions upgraded. This year 11 companies exhibited at the German pavilion, while the Singapore pavilion welcomed 8 exhibitors. These exhibitors showed specialty cables, automation, sealing detection equipment, plastic welding technology, dialyzer assembling equipment, software encryption services, and non-standard precision components.

Concurrent Conference and Onsite activities grasp industry trends

Medtec China 2018 invited 49 keynote speakers from the government, enterprises and agencies to talk about hot topics including Regulation, Quality, Technology, Markets and Investment. 900 conference delegates participated in more than 61 sessions. Topics included: Chinese Regulatory Updates and Compliance, MDSAP updates and FDA Inspection, Concepts and Ways of Medical Device Design, and Pack&Ster Hub.

Concurrent activities provided an efficient interaction platform for exhibitors and visitors. The Exhibitor Theatre, the 4th Market Report Track of Medical Device Industry, the Elkem Silicones Healthcare Seminar, the Wuxi AppTec Medical Device Testing Business China Launch Event, the MicroPort technology seminar, the Quality Expo and the MDEA global medical design excellence awards all provided more take-aways for exhibitors and visitors.

Medtec China 2019 will be held at the Shanghai World Expo Exhibition & Convention Center September 25-27th, 2019. To obtain more information, please visit our website:

Media\Exhibit\Visit\Conference Contact:

Sophia XU
UBM China
T: +86 10 5730 6095

Source: Medtec China

- ASIA TODAY News Global Distribution

Bumrungrad International Hospital Implements InterSystems TrakCare with Early Benefits to Patient Satisfaction, Safety, and Efficiency
Nov 06, 2018

Eighteen-Month Digital Transformation Leads to Record High Patient Satisfaction Ratings in Several Departments at World Class, Multi-Specialty Private Hospital

BANGKOK, Thailand, October 30, 2018 – InterSystems, a global leader in health information technology, and Bumrungrad International Hospital have implemented the InterSystems TrakCare® electronic medical record (EMR) solution to support world-class care delivery, with early benefits achieved in patient satisfaction, safety, and efficiency.

Bumrungrad International Hospital is accredited by Joint Commission International and recognized as one of the world’s leading and most technologically advanced hospitals. Specializing in tertiary care with a patient-centric approach, it is one of the largest private hospitals in Southeast Asia, with 580 beds and more than 30 specialty centers. The hospital has 1,300 physicians, serving 1.1 million patients annually.

Bumrungrad has implemented TrakCare throughout the hospital. By utilizing TrakCare’s unified Patient Administration and Clinical capabilities – including support for Emergency, Maternity, Surgery, Radiology, Clinical Laboratory, and Pharmacy – it has already made a significantly positive difference to patient experience.

“We achieved record high patient satisfaction ratings of over 95% over the past few months in several departments,” said Kenny Lim, Chief Information Technology Officer, Bumrungrad International Hospital. “Paper usage across the entire hospital has fallen dramatically with TrakCare’s deployment, and the increased use of electronic communications has helped to reduce journey times for patients.”

With the near elimination of paper and an automated reporting system, the time taken to complete a health screening or checkup, for example, has been reduced. Other early benefits include improvements that contribute to patient safety and organizational efficiency.

Physicians and medical staff now use TrakCare to manage all patient interactions, facilitate clinical workflows, and support them in making the best informed decisions. Doctors and nurses are able to quickly and easily view a comprehensive, unified record for each patient and there is improved communication between care teams and departments.

TrakCare’s clinical decision support system provides safety alerts for a range of risks including drug interactions, therapeutic duplications, and duplicate orders. It is also integrated with patient monitors and used to deliver closed-loop medication management, designed to minimize medical errors and provide safeguards to help improve patient safety.

As an early adopter of TrakCare Lab Enterprise, the world’s first laboratory business management system and a unified module within TrakCare, Bumrungrad is now gaining visibility into clinical laboratory processes to support better operational decision-making. InterSystems HealthShare® is also enabling interoperability with non-TrakCare systems within and outside the hospital.

Bumrungrad expects to achieve further benefits to the quality of care in the future. With all patient data captured in one database, it can analyze data to achieve continuing reductions in unexpected outcomes. “We expect to achieve continual improvements in clinical outcomes with the EMR,” said Lim. “Over the next few years, hospitals will see almost all medical tools become digital. The challenge will be to get them all integrated with the EMR and managed in a single holistic solution.”

“InterSystems is proud to be partnering closely with Bumrungrad International Hospital to deliver world class care to patients,” said Kerry Stratton, InterSystems Managing Director, Asia Pacific. “The hospital joins a community of TrakCare customers in over 25 countries who benefit from global best practice built into the product and regional configurations proven to support local market needs. We believe this digital transformation will help Bumrungrad to innovate faster, while delivering better outcomes.”

About Bumrungrad International Hospital
Bumrungrad International Hospital is an internationally accredited, multi-specialty hospital located in the heart of Bangkok, Thailand. Founded in 1980 and listed on the Stock Exchange of Thailand in 1989, it is one of the largest private hospitals in Southeast Asia, with 580 beds and over 30 specialty centers. Bumrungrad International offers state-of-the-art diagnostic, therapeutic and intensive care facilities in a one-stop medical center. Bumrungrad International serves 1.1 million patients annually, including over half a million international patients. As the first JCI accredited hospital in Asia and the first hospital in Thailand with a lab accredited by the College of American Pathologists (CAP), Bumrungrad is consistently recognized as one of the leading hospitals in the world.

About InterSystems
InterSystems is the information engine that powers some of the world’s most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems has been a strategic technology provider since 1978. InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 100 countries. For more information,

- ASIA TODAY News Global Distribution

3rd Annual Radiology Meeting in UAE Concludes on a High Note
Nov 03, 2018

Dubai – United Arab Emirates, 2 November 2018: The 3rd Annual Radiology Meeting in UAE - ARM concluded today at the Dubai International Convention and Exhibition Centre, with the active participation of many leading scientists, physicians, radiologists and industry professionals from across the globe. Held under the patronage of His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of Dubai Health Authority, ARM, featured a number of dedicated scientific sessions, case studies and lectures in radiology which greatly improved the knowledge and understanding of visitors and participants.

On the final day of ARM, specialists and experts in radiology, focused their attention on ‘Pediatric Imaging’ featuring a number of dedicated scientific sessions such as: Fetal Brain MRI, Imaging evaluation of pediatric congenital brain and spine malformations and Pediatric Brain Tumors: Step by Step Imaging Evaluation. In addition, the conference, included separate workshops on ‘Breast Imaging’ and featured a number of discussions on various topics including ‘Traumatic Spine Injuries – Imaging Evaluation’ and a Systematic approach to MRI interpretation of degenerative spine pathologies.

From her side, Dr. Amna Kashgari from the Kingdom of Saudi Arabia said: “Pediatric Imaging helps us diagnose the diseases in a quick and accurate way. In my lecture, I focused on diagnosing the brain tumors and the genetic diseases in the brain and the spine and how crucial the proper diagnosis is for both the child and parents, as the early discovery of the genetic diseases helps in treating the patient and the early rehabilitation. The lecture also concentrated on the diagnosis of brain tumors in children and how to perform MRI on them as it is the only method that leads to the accurate diagnosis before taking a biopsy.”

Commenting on the challenges that face the radiographers, Dr. Kashgari stated: “There are two major difficulties that usually face the radiographers; 1) general anesthesia to perform the MRI, and 2) exposing the children to the rays when carrying on CT scan; therefore, to overcome these matters, radiologists must follow certain techniques while performing the examination.”

While commenting on his participation at ARM, Dr. Professor Edward Lee, Assistant Professor of Radiology, Harvard University, USA said, “As an international speaker who has participated in many international meetings in more than 50 different countries, I am very impressed with the scale and depth of the Annual Radiology Meeting in UAE. The rich scientific conference program, with up-to-date comprehensive lectures and scientific sessions, will certainly go a long way in addressing the current challenges facing radiologists. Dubai is certainly a great venue for major international medical conferences such as the ARM, as it has become a major hub for economy and healthcare in the region and the world.”

He added, “For the past several decades, the role of radiology has changed substantially. Instead of just providing imaging study reports to other clinicians, today, the healthcare system is very complex and we, as radiologists feel very proud to be at the center of this complex healthcare system. As radiology is a highly specialized department, we are not only playing an important role in taking care of patients but are also working very closely with other physicians from different medical fields.”

‘Pediatric Imaging’ comes with a unique set of challenges for radiographers who not only need to recognize and follow the instincts of children but also gain the child’s trust and cooperation for their imaging test. In addition, the medical use of radiation to diagnose and treat children and the various protection and safety issues involved while dealing with children put an additional burden and responsibility on radiographers. Pediatric Imaging is required to diagnose and treat various pathologies in children such as Leukemia and Meningitis among others.

As ‘imaging evaluation of congenital brain malformations’ is a key topic in the conference, studies suggest that birth trauma in infants is more commonly reported in many developing nations in Asia, Africa and Latin America. The role of a radiologist in such cases is to promptly and accurately recognize and report the degree of injury in order to avoid delays in treatment and allow clinicians to determine an appropriate strategy for treatment.

With so many advances taking place in the radiology field, ARM 2018 featured a range of new technologies to keep abreast with the latest while also educate visitors and participants about what to expect in the future. This year, ARM exhibition showcased the iCALC algorithm, a unique personalized software, which is valuable to the patient, radiologist and cost efficient for the hospital. Moreover, ARM is displaying the world’s first CE-Certified AI application for brain diagnosis, that uses deep learning technology to analyze MRI and CT image and automatically recommends a diagnosis and report for doctors to review, within seconds.

Apart from offering a key platform for learning, the 3rd edition presented the ‘ARM 2018 Recognition Award’, which recognizes the unique contribution of one radiologist and one radiographer, who made a key difference to the practice and profession in the UAE. In addition, the conference featured the ‘Emirates Radiology Cup’, which awards the best case presented by specialists and residents and the ‘Poster Presentation competition’ allowing students, radiographers and radiologists to compete and showcase their research papers while also giving them an opportunity to exchange ideas and collaborate in the future.

Over the 3 days, ARM 2018 attracted the participation of over 1700 visitors and participants from the UAE and abroad while also witnessed the attendance of 45 world renowned speakers representing many countries such as USA, UK, France, Italy, Switzerland, Norway, India, Saudi Arabia, Jordan and the UAE.

The Annual Radiology Meeting in UAE is organized by INDEX Conferences and Exhibitions – a member of INDEX Holding in collaboration with the Radiology Society of the Emirates. The event is sponsored by Philips – Patient Experience Partner, Siemens Healthineers – Premier healthcare partner, Dansys Group- Innovation Partner, Fujifilm - Gold Partner, GE Healthcare - Knowledge Partner, AGFA Healthcare - Silver Partner and INFINITT MEA - Silver Partner, Paxera Health – Technology Partner and supported by UIBC and the European Society of Radiology [ESR].

-End -

Suzan Mounzer
Public Relations & Social Media Manager
Tel: +971 45208888
Mob: +971 569070443

- ASIA TODAY News Global Distribution

Asia Derma debuts in Singapore, December 2018
Oct 31, 2018

Asia-centric edition of the leading dermatology and aesthetics conference and exhibition by INDEX Holding to launch, after 20 years' experience cultivating Dubai Derma

SINGAPORE, Oct. 31, 2018 -- Asia Derma, the first Asia Pacific Dermatology and Aesthetic Conference & Exhibition of its kind, is poised to be the leading industry conference for skin professionals in the region. The event will take place at the Suntec Singapore Convention and Exhibition Centre, between 5th and 7th December 2018.

As the first two-in-one conference to uniquely combine both therapeutic and aesthetic dermatology in a single platform, Asia Derma will deliver expertly curated content, skills development, Asia-centric trends and insights from industry leaders - as well as unrivalled brand exposure. The Scientific Conference and Trade Exhibition components collectively bring together Asia's leading aesthetic dermatology professionals and brands, in the unrivalled three-day platform. Dermatologists, anti-aging aestheticians, general practitioners and government health regulators will be able to benefit from the insightful conference sessions led by globally and regionally renowned skin health professionals, in addition to discovering the latest treatments.

Esteemed Professor Goh Chee Leok, Chairman of the Asia Derma 2018 Scientific Committee, elaborates, "The inaugural Asia Derma Conference & Exhibition has a comprehensive scientific programme that will provide an exceptional opportunity for practitioners to share their expertise, improve their knowledge and enhance their skills in dermatology and aesthetic medicine. The trade exhibition, running parallel to the conference, will also create a synergistic platform for industry professionals to introduce the latest in skincare technology and medical care."

A key player in the region's medical device industry, Korea, is Asia Derma's Country of Honour in collaboration with IBITA. Korea's aesthetic medical device market was valued at an estimated $153.22 million in 2016 and is expected to grow at a compound annual growth rate of around 11.61%. These investments have enabled Korea to become a nation of authority in the medical device industry, with unrivalled insight and expertise in the space. Attendees can experience this first-hand through the various Korean brands and exhibitors participating, including Eunsung Global, GTG Wellness and Dermafirm.

Anas Al-Madani, Vice-Chairman and Group CEO of INDEX Holding and organiser of Asia Derma and Dubai Derma comments, "Market research suggests Asia-Pacific is the fastest growing market for dermatology devices and is a key driver for the quest of effective skincare solutions. Asia Derma's debut in Singapore is a nod to the city state's standing as a financial, business and lifestyle hub in Asia and event delegates from the region can expect a first class global international skincare event."

For the latest information on exhibitors, more information about Asia Derma, please visit

About INDEX Holding

Based in the UAE with a strong portfolio of events in the medical sector, INDEX Holding opened its new branch in Singapore early 2018, due to its strategic location in Asia-Pacific and strong economic and commercial ties with the UAE. Through its Singapore branch, INDEX Holding aims to create new business opportunities through a number of scientific and commercial events in the Asia-Pacific region.

Index Holding has organised events in Germany, Italy and Japan, as well as Korea where the company has held a branch office in Seoul since 2006.

Source: INDEX Holding

- ASIA TODAY News Global Distribution

NKF #AMBILSERIUS About Promoting Organ Donation
Oct 22, 2018

Kuala Lumpur, October 2018 – In conjunction with Minggu Kesedaran Pendermaan Organ (MKPO) Peringkat Kebangsaan 2018, the National Kidney Foundation (NKF) of Malaysia had initiated a unique approach to promote organ donation with mobile cruisers. The NKF team distributed flyers containing organ donation statistics and information about organ donation along with green pens to drive awareness and commitment for organ donation between 17-21 October.

“Almost 25,000 patients are currently on the waiting list for organ transplant in Malaysia; however only 1.3% per million population of Malaysian has registered as organ donor pledgers. Through this effort, we strive to create awareness of the struggle of those with kidney disease that are hoping for transplants as well as to encourage the public to recognize the life-saving significance of organ donation,” said Chua Hong Wee, Chief Executive Officer of NKF.

The mobile cruiser team went around Klang Valley areas including Subang Jaya, Petaling Jaya, Shah Alam, Kelana Jaya, Damansara and Kuala Lumpur, targeting public places such as universities and shopping malls in order to spread the message to members of the public of all ages. There were also fun and informative activities such as live interviews with the public so as to understand Malaysians’ perspectives and knowledge towards organ donation in the country. Interactive games with free gifts, as well as special appearance of the movie character mascots brought cheers to the visitors. The campaign hashtag is #ambilserius.

“NKF continuously strives to create awareness on kidney disease – from preventive measures to providing assistance to the underprivileged suffering from the disease. On 27 and 28 October 2018, NKF Malaysia will also be hosting the 15th Annual Dialysis Meeting 2018 which is a patient-centred approach to dialysis care towards a better quality of life for dialysis patients in Malaysia,” Chua added.

To find out more about National Kidney Foundation and 15th Annual Dialysis Meeting event on 27 & 28 October 2018, log on to the organisation’s website at


National Kidney Foundation of Malaysia
The National Kidney Foundation (NKF) Malaysia is a non-profit charitable organization dedicated to helping Malaysians suffering from end stage kidney failure who lack access to or cannot afford dialysis treatment. NKF currently has over 1,600 dialysis patients receiving subsidized dialysis treatment in over 28 dialysis centers nationwide.

GO Communications Sdn Bhd
Celine Lau / Justin Ooi
Tel : 603 7710 3288 / Fax : 603 7710 3289
Email : /

- ASIA TODAY News Global Distribution

Impact of Digital Trends on Aesthetic Dentistry Discussed on the Last Day of IADC 2018
Oct 02, 2018

Abu Dhabi, United Arab Emirates, 29 September, 2018: The first edition of the International Aesthetic Dental Conference (IADC) dedicated to specialists and experts in ‘Aesthetic Dentistry’, successfully concluded today in Abu Dhabi. The 2-day conference highlighted the impact of digital trends on Aesthetic dentistry and how new technologies are enabling modern treatments in dentistry.

During the IADC conference, world renowned specialists and doctors discussed a wide variety of topics in Aesthetic dentistry which included: How to Achieve Aesthetic Restorations, Composite vs Ceramic: Aesthetics Protocols, Planning to Execution, Combining Digital and Analog Concepts in Rehabilitations and Advanced and approved techniques for a predictable single implant placement in the esthetic zone.

Commenting on his topic ‘3D Engineering in Dentofacial Rehabilitation’, Prof. Dr. Wael Att, Chairman, Department of Prosthodontics, Tufts University, USA, said, “The ultimate goal of digital technologies in Aesthetic dentistry is to improve the quality and accuracy in delivering proper diagnosis and treatment of the dental patient. With access to new technologies now more possible than ever, digitally-driven 3D engineering tools are increasingly being used in reconstructive dentistry. In many cases such digital tools are helpful in improving data acquisition and assessment and enabling superior treatment options for patients. My presentation was about discussing various possibilities and advantages when using a conventional or a digital approach such as 3D engineering and its impact on dento-facial rehabilitation.”

While commenting on his session titled, “Approved & Advanced Techniques for a Predictable Single Implant Placement in the Esthetic Zone”, Dr. Pascal Marquardt, Founder and Director of Marquardt, Germany, said, “Dental implants in the esthetic zone, which is the visible area seen upon full smile, including the teeth and lips, pose a serious challenge in dental implantology. In order to achieve the right results, a full precise pre-operative case planning as well as the correct positioning of the implant is a must for a long-lasting effect.”

He added, “In my presentation, I presented an evidence based, approved concepts and guidelines for the most effective usage of dental implants, particularly on a single tooth. In addition, the presentation highlighted conventional techniques as well as the relative advantages and new possibilities while using 3D diagnostic and guided positioning of implants. As soft tissue management is key to success for long term stability in implant cases in the esthetic zone, I offered many strategies, discussed key advantages and risks of immediate implant placement while also exploring new ways and techniques on a step-by-step basis in different clinical settings.”

While it is obvious that digital trends have surely revolutionized the way dentistry is practiced, doctors and specialists highlighted that the demand for naturalness and excellence in Aesthetic dentistry has considerably increased over the last few years. It was also mentioned that with so many new technologies now readily accessible, it is now possible to achieve all kinds of dental restorations while not compromising on the natural appearance of dental structures.

In conclusion of the conference, organisers have announced the dates of the 2nd edition that will be held from 24 – 26 October 2019 in the capital Abu Dhabi. The International Aesthetic Dental Conference – IADC is jointly organized by INDEX Conferences and Exhibitions – a member of INDEX Holding and the Arabian Academy of Esthetic Dentistry (ARAED). The event was held this year in partnership with AEEDC Dubai and Abu Dhabi Department of Culture and Tourism and was sponsored by Nobel Biocare, SIC, and Oral B.

- End -

- ASIA TODAY News Global Distribution

PCHi Technology Summit 2018 Empowers Attendees with Fresh Perspectives
Sep 05, 2018

Beijing, 5 September 2018 --( ASIA TODAY )-- After a successful inaugural run in Shanghai last year, the PCHi Technology Summit returned to the favorable reception of the industry once again. Held from 27 – 28 August at the luxurious W Guangzhou in China, the event attracted around 500 beauty and personal care trade professionals (up almost 50% from last year) in attendance and over 20,000 views online.

This year’s Summit agenda was carefully curated by PCHi’s Cosmetics Science and Technology Innovation Committee (CSTIC), around the theme of Empowered for Renewed Vitality and PCHi’s new key branding pillars of Technology • Power • Spirit. For this edition, organizers chose to focus on the hot topics of anti-aging and sensitive skin, and their main objective was to provide inspiration for industry players to drive technological innovation and research development.

To address attendees’ needs and concerns, speakers not only tackled broad issues such as global market forces, industry trends, and changes in regulatory framework, but they also covered in-depth discussions on formulation technologies, efficacy evaluation, and clinical mechanisms.

Speaking at the event’s opening address, Mr Ying Jun, Vice President, RSE, shared, “According to industry sources, China’s cosmetic market is forecasted to be valued at RMB 490 billion by 2019. Analysts expect great growth potential in the Chinese personal care and home care industry, and this reflects our market’s importance in the global context. Over the last 11 years, our team has been focused on promoting technological innovation, and the PCHi brand is now widely recognized as the industry’s platform of choice — whether for sourcing, networking, or learning. As the personal care and beauty industry continues on its relentless pursuit for excellence, we look forward to making a positive impact by enabling businesses to soar to greater heights.”

Leaders from the China Association of Fragrance Flavour and Cosmetic Industries (CAFFCI), China Cleaning Industry Association (CCIA), and China Research Institute of Daily Chemical Industry (RIDCI) also expressed their views on the industry’s current situation and future trends. Mr Chen Shaojun, President of CAFFCI revealed, “According to our statistics, over 4,500 cosmetics companies in China have obtained production qualifications as at July 2018, and they account for nearly RMB 320 billion worth of products manufactured last year. Market segmentation by specific claims has helped to boost our country’s cosmetics manufacturing sector significantly.”

Sculpting a Brighter Future Together

China’s personal care market is at a point of inflexion and analysts see huge potential for advancement in the years ahead. At the Summit, various industry leaders took the opportunity to share their views on growth strategies for domestic enterprises.

A sentiment that surfaced several times was a reminder for companies to focus more on the big picture — how one can contribute to driving the industry forward and upward — and less on short-term gains, monetary or otherwise. In particular, even as the industry seeks to meet the consumer’s ever-evolving demands, speakers encouraged businesses to ensure two fundamental building blocks are handled well: technological innovation and product safety.

Delegates were exposed to multiple facets of each hot topic as they got to hear from a mixture of subject matter experts — including a dermo-cosmetics clinician, scientist, formulator, product designer, research analyst, regulatory authority, and academia.

Apart from the plenary sessions, Summit delegates were also able to discover some of the latest offerings presented by more than 30 exhibitors.

Similar to last year’s event, selected sessions of the Summit were streamed live so as to benefit the industry at large. Trade professionals who were unable to attend the event can now view the recordings at

Recognizing Industry Partners’ Contributions
At the event, RSE also took the opportunity to recognize 27 long-standing partners that have made significant contributions to the global personal care and home care industry. These distinguished partners include trade associations, market research firms, trade media, and industry suppliers.

  1.       BASF (China) Company Limited
  2.       Connell Bros. (Shanghai)Co. Ltd.
  3.       Cosfa International Trading (Guangzhou) Co., Ltd.
  4.       Croda China Trading Co., Ltd
  5.       DKSH (Shanghai) Ltd.
  6.       DSM Nutritional Product Asia Pacific
  7.       Evonik Specialty Chemicals (Shanghai) Co., Ltd.
  8.       Guangdong BioMax Si&F New Material Co., Ltd.
  9.       Guangzhou CDLUNION Biotechnology Co., Ltd
  10.     Guangzhou DX Chemical Co., Ltd.
  11.     Guangzhou Jiahua Chemical Co., Ltd.
  12.     Guangzhou Tinci Materials Technology Co., Ltd.
  13.     Hunan Silok Silicone Co., Ltd.
  14.     Sethic Innovation Labo
  15.     Shin-Etsu Silicone International Trading (Shanghai) Co., Ltd
  16.     Symrise Shanghai Ltd
  1.     China Association of Fragrance Flavor and Cosmetics Industries
  2.     China Cleaning Industry Association
  3.     China Research Institute of Daily Chemical Industry
  4.     European Union Chamber of Commerce in China
  5.     Euromonitor International
  6.     Mintel
  7.     China Cosmetics Review
  8.     Colour Cosmetics
  9.     Cosmetics & Personal Care
  10.     Cosmetics Business Online
  11.     Cosmetics Newspaper


Next Stop: PCHi 2019

The 12th edition of PCHi will be held from 26 to 28 February 2019 at the Guangzhou Poly World Trade Center, China.

Pre-register online for complimentary visitor access at before 12.00am (GMT+8) on 22 February 2019.

For more information about PCHi 2019, please, or connect with PCHi on social media.


About PCHi

The Personal Care and Homecare Ingredients (PCHi) trade show is China's #1 Sourcing Platform for the Global Personal Care Industry. As an innovation-led event, PCHi provides cosmetics, home and personal care manufacturers, ingredients suppliers, cosmetics packaging, machinery and product testing providers from all over the world with a quality platform for ingredients sourcing, gaining insight into global trends, and networking with world-class experts.

- ASIA TODAY News Global Distribution

Cadrock Secures US$5m for Therapy Targeting $35 billion Heart Disease Market
JCN Newswire
Sep 03, 2018

- Enrolls first clinical trial patients in Sydney, Australia

SYDNEY - (ACN Newswire) - Cadrock Pty Ltd, which owns an investigational prevention and treatment therapy for coronary artery disease (CAD), has secured a US$5 million seed investment from a Chinese investor to fund clinical trials.

Cadrock is potentially disrupting the entire heart-care sector by proposing CAD is caused by bacterial infection.

Cadrock data is backed by a clinical trial treating CAD as an infection with an antibiotic therapy in London, UK, which demonstrated a 36% reduction in Major Cardiac Events (MCEs) (STAMINA).

"Where there is inflammation, look for infection," says Professor Borody, who is well known globally for discovering the cure for the peptic ulcer bacterial infection, using a triple antibiotic therapy.

His triple antibiotic therapy for peptic ulcers prevented 18,655 premature deaths and saved the Australian Government an estimated AU$10.03 billion (THEMA Report).

Professor Borody has now developed and patented a new investigational triple antibiotic therapy to combat the infection believed to cause CAD.

"The Cadrock therapy is targeting the $35 billion CAD market and is the only therapy focused on the cause of CAD rather than suspected risk factors," said Professor Borody.

The first Cadrock interventional clinical trial of the triple therapy at Liverpool Hospital, Sydney Australia, has just enrolled its second patient.

The study is recruiting 60 people with CAD and will "evaluate the effect of antibiotic combination therapy on objective measures of improvement in coronary flow as determined by fractional flow reserve (FFR) intra-coronary imaging (Intravascular ultrasound [IVUS] and/or Optical Coherence Tomography [OCT]) in subjects undergoing percutaneous coronary intervention (PCI) with non-critical lesions in non-culprit arteries."

Professor Borody is most famous for discovering the triple antibiotic therapy for peptic ulcers in 1985, after Nobel Prize recipients Barry Marshall and Robin Warren discovered infection as the cause.

Professor Borody said, "CAD heart disease and stroke are the world's biggest killers with around 15 million deaths in 2015. In the US alone heart disease is the leading cause of death for both men and women - 610,000 people die of heart disease in the United States annually. (Source: CDC).

In China, about 230 million or 1/5 people have cardiovascular disease. (Source: Harvard University)

Additionally, peripheral vascular disease worldwide afflicts around 200 million people.

Statins form part of the first line treatment of CAD but reduce Major Cardiac Events (MCEs) in preventative studies by as little as 0.2-0.6%. (Jupiter)

About Cadrock

Cadrock Pty Ltd has a novel investigational prevention and treatment therapy for coronary heart disease (CAD) developed by Professor Thomas Borody, who discovered the cure for peptic ulcers. The Cadrock therapy is targeting the $35 billion CAD market and is the only therapy focused on the cause of CAD, rather than suspected risk factors. The Cadrock therapy is now in clinical trials in Australia. For more information, and access to the Digify investor VDR, please contact investor relations at

- ASIA TODAY News Global Distribution

Company JCN Newswire
Contact Tiara Liu
Telephone +81-3-5791-1821
Medical Devices ASEAN 2018 welcomed 3,639 trade visitors from 31 countries
Aug 30, 2018

The first edition of Medical Devices ASEAN 2018 ("MDA 2018"), the international exhibition and congress on medical devices, technologies, services and general healthcare, reflected its success as the gateway to ASEAN’s medical devices industry. Over 125 brands and companies from 10 countries alongside more than 3,639 national and international trade visitors from 31 countries gathered, to explore this new chapter in ASEAN’s medical devices industry; raising the bar for medical devices standards and supporting the push to position Thailand as the medical hub of ASEAN.

MDA 2018 as an integrating platform for medical devices industry
Mr. Loy Joon How, General Manager, IMPACT Exhibition Management Co., Ltd. (“IMPACT”), said, “The first edition of MDA 2018 exceeded our expectations due to strong supports from the public and private sectors. This event showcased the latest medical innovations and technologies, covering a comprehensive range of products and services, including general surgery; orthopedic surgery and rehabilitation medicine; radiology and diagnostic imaging; medical laboratory; IT in healthcare; medical instruments and consumables.”

Mr. Veerasith Sinchareonkul, Executive Director, Sri Trang Gloves (Thailand) Co., Ltd., who exhibited at MDA 2018, stated, “We are a major player in the medical and healthcare industry and we recognized MDA 2018 as a vital event for the industry. We exhibited at the event to contribute to the expansion of Thailand’s medical device market. Exhibiting at MDA 2018 served as a public relations tool to increase the awareness of our business, enhance our reputation, and present our products to our customers. This show is an all-encompassing medical devices exhibition in the region."

"We believe that MDA 2018 is an effective platform for us to link up with other potential partners. The feedback from the attendees is quite positive, and the show is fabulous," added by Jack Cheung, a representative from Logital Co., Ltd., Hong Kong.

The MDA Congress, with six academic conferences and an industry forum, welcomed over 1,559 delegates. Attended by lab professionals, doctors, general practitioners, orthopaedists, nurses, radiologists, radiographers, biomedical engineers and other specialists, the sessions were strongly supported by the Royal College of Orthopaedic Surgeons of Thailand; the Nurses’ Association of Thailand under the Royal Patronage of Her Royal Highness the Princess Mother; the Radiological Society of Thailand; the Thai Association for Medical Instrumentation; the Thai Medical Informatics Association; the Association of Medical Technologists of Thailand under the Patronage of H.R.H. Princess Soamsawali; and the Thai Medical Device Technology Industry Association

Mr. Loy concluded, “Under the theme ‘Building the Future of Healthcare’, MDA aimed to serve as an integrated healthcare platform to facilitate business among manufacturers, suppliers, and end-users; and to offer valuable insights into the healthcare market in ASEAN. We look forward to a more vibrant and comprehensive edition next year and we are very excited to facilitate these companies’ journey to establish and expand their presence in the ASEAN’s medical devices industry.”

The second edition of MDA will be held on 10-12 July 2019, at Hall 1-2, IMPACT Exhibition Center, Bangkok, Thailand.

For more information on the definitive exhibition, please visit

- ASIA TODAY News Global Distribution

Company Impact
Telephone +662 833 5308
Mega Oncology Conference successfully held at Shenyang’s EXPO
Aug 28, 2018

Shenyang, 27 August 2018 --( ASIA TODAY )-- The Shenyang New World EXPO (“EXPO”) successfully hosted one of the largest Chinese international conferences ever to be held in northeast China. The 2018 Chinese Conference on Oncology was held on 18-19 August.

Delegate attendance on the opening day of the Conference exceeded 18,000. The event maximized the use of all areas of the venue including the 24,000 sqm (258,000 sq. ft.) of exhibition/multi-purpose space and 4,000 sqm (43,000 sq. ft.) of meeting space.

During the 2 day event, the venue provided F&B services as well as venue safety and security services to ensure efficient crowd management and transportation logistics. Shenyang’s Security and Traffic Bureaus were also outstanding in their support of the staff and event.

EXPO General Manager Diane CHEN said, “This extraordinary mega-conference was a real challenge due to the attendance and technical details. Its success is a credit again to the tremendous commitment of our EXPO staff and the superb cooperation received from our government bureaus. We have shown again how valuable EXPO can be to the community in hosting such events which will only add significantly to the positive economic impact of the city and Liaoning Province.”

Shenyang New World EXPO Venue Management Chairman Cliff Wallace acknowledged the leadership provided by EXPO’s management and the standards by which the organizers planned and executed the Conference. It was an endorsement of the venue, the city and the government. With such ongoing cooperation, Wallace said, “The meeting and exhibition industry of Shenyang and Liaoning can only expect healthy growth.”

The Conference was sponsored by China Anti-Cancer Association (CACA), and organized by Liaoning Cancer Hospital & Institute and Liaoning Anti-Cancer Association. The Conference also enjoyed the highest number of attending academicians, collected papers and participating experts of any of its previous conferences.

The Conference set-up included 1 main venue, 8 theme venues and 77 parallel sessions holding academic forums with 923 renowned scholars and experts specialized in oncology across the world. The number of people watching live broadcast online reached 1.08 million, involving 210 media outlets.

The Conference included parallel sessions to discuss new ideas, new techniques and new methods concerning common treatment like radiotherapy and chemotherapy, anti-cancer drugs, Minimally Invasive Surgery (MIS) and Percutaneous Coronary Intervention (PCI), therapeutic endoscopy, biotherapy, nutritional oncology, nuclear medicine, and psycho-oncology and oncologic nursing, as well as exchange opinions on development of pathology of neoplasia, tumor markers, epidemic diseases and etiology of cancers.

For more information, please contact:

Diane CHEN - or

- ASIA TODAY News Global Distribution